Abstract

Despite a constant evolution in stent/scaffold design, stent failure is still perceived as a clinical problem. The process of drug eluting stent (DES) struts thinning that occurred in the last year with the introduction of cobalt-chromium devices has been of utmost importance to significantly reduce the incidence of stent thrombosis and restenosis